NCRN086 - INDUSTRY STUDY.

Trial Profile

NCRN086 - INDUSTRY STUDY.

Suspended
Phase of Trial: Phase II

Latest Information Update: 10 Aug 2012

At a glance

  • Drugs Carlumab (Primary)
  • Indications Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
  • Focus Therapeutic Use
  • Sponsors Centocor
  • Most Recent Events

    • 31 Jul 2010 Status changed from not yet recruiting to suspended as reported by United Kingdom Clinical Research Network record.
    • 02 Jul 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top